
Dan Simenc
FSA, MAAA
Consulting Actuary
Tampa, FL, US
Dan Simenc is a consulting actuary with the Milliman Tampa office. He joined the firm in February 2012.
Experience
Dan has extensive experience helping payers, manufacturers, providers, and employers navigate the U.S. health insurance landscape with an emphasis on Medicare Advantage and Part D. His work includes pricing, rate filings, financial reporting, market access strategy, and real-world evidence research.
Professional Designations
- Fellow, Society of Actuaries
- Member, American Academy of Actuaries
Education
- BS (Summa Cum Laude), Mathematics and Economics, Boise State University
Publications
Read their latest work
Article
Medicare drug price negotiation: Navigating the next wave of maximum fair prices
12 January 2026 - by Jake K. Klaisner, Katherine M. Holcomb, Dan Simenc
Deeper discounts in the latest round of negotiated prices for Medicare Part D drugs may indicate how future negotiations will play out.
Article
Adapting to the IRA: 5 manufacturer considerations for Part D formulary access negotiations
08 December 2025 - by Dan Simenc, Pepper Huang
We discuss five key considerations for manufacturers negotiating Medicare Part D formulary access in the wake of the Inflation Reduction Act.
Article
Medicare price negotiation: Year 2 selection expands to new therapeutic areas
07 February 2025 - by Dan Simenc, Jake K. Klaisner, Katherine M. Holcomb
We provide some insights on Medicare price negotiation's year-two selection, which expands to new therapeutic areas.